Back to search

Aristotle University Of Thessaloniki (AUTH)

Κλινική και ανοσολογική μελέτη της επίδρασης των βιολογικών παραγόντων στη νεανική ιδιοπαθή αρθρίτιδα

Abstract

dc:description

The aim of the study was: a) to evaluate the long-term safety and efficacy of biologic agents in patients with Juvenile Idiopathic Arthritis (JIA) and b) to investigate the impact of anti TNFs on Τ cell activation and proliferation response. The safety and efficacy of infliximab etanercept adalimumab and anakinra were assessed in 69 patients (99 sessions) with JIA aged 2-17 years. The impact of anti TNFs on Τ cell function was studied in 24 JIA patients under conventional therapy (2,5-16 yrs) and 13 JIA patients under anti TNFs (3-20 yrs). The safety analysis included the registration of adverse events (AEs). Efficacy was assessed using the criteria of the American College of Rheumatology (ACR) Pediatric 30, 50, 70, 90 and 100 for disease improvement. The percentage of total Β and Τ cells the Τ cells populations CD3+CD4+, CD3+CD8+ and the activation markers CD69, CD71, CD25 and HLA DR of CD3+ Τ cells were determined using flow cytometry. Lymphocyte proliferation was induced in vitro by mitogens. This method evaluates the lymphocyte activation and proliferation response. Common infections were recorded in 24.2% of sessions serious infections in 3% and serious AEs in 4% of sessions. During infliximab treatment and until the end of 2nd year all patients flared. During etanercept treatment and from the 1st until the 5th year an ACRped 50 was achieved in the 86,4%, 91,9%, 90,1%, 86,7% and 85,7% of sessions respectively. During the first 4 years of adalimumab treatment an ACRped 50 was achieved in the 85,29%, 79,31%, 91,67% και 88,9% of sessions respectively. Remission that maintained for over 2 years was achieved by all 3 patients who received anakinra. While the anti TNFs decreased the percentage of activated CD3+ Τ cells they did not normalize their proliferation response due probably to the immunosenescence occurring in JIA.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Διάφα, Κωνσταντίνα

Subjects

dc:subject × 22

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27025

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Διάφα, Κωνσταντίνα. Κλινική και ανοσολογική μελέτη της επίδρασης των βιολογικών παραγόντων στη νεανική ιδιοπαθή αρθρίτιδα. Aristotle University Of Thessaloniki (AUTH), 2011. http://hdl.handle.net/10442/hedi/27025